Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach
These consolidated guidelines provide guidance on the diagnosis of HIV infection, the care of people living with HIV, and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. They are structured along the continuum of HIV testing, care and treatment. Behavioural, structural and biomedical interventions that do not involve the use of ARV drugs are not covered in these guidelines. The 2013 consolidation process combines and harmonizes recommendations from a range of WHO guidelines and other documents, including the 2010 guidelines on using antiretroviral therapy (ART) for HIV infection in adults and adolescents, in infants and children, and for treating pregnant women living with HIV and preventing HIV infection in infants. Comprehensive guidance is now provided on using ARV drugs across age groups and populations of adults, pregnant and breastfeeding women, adolescents, children and key populations. The guidelines also aim to consolidate and update clinical, service delivery, and programmatic guidance.

Civil Society and Key Populations and the Country Dialogue Process, Guidance Note: Navigating the New

Civil Society and Key Populations and the Country Dialogue Process, Guidance Note: Navigating the New
This guidance document, the second in the series Navigating the New Funding Model, is intended as a tool for civil society organizations which are engaged in, leading, or monitoring country dialogues. An explanation of the key features and expected outcomes of the country dialogue process is followed by a discussion of country dialogues in practice over the past year. A review of existing analyses and interviews with civil society participants in country dialogues inform a discussion of the principles of effective country dialogues. For the purposes of this document, “effective” country dialogues are those which include significant and meaningful civil society and key population participation and inform a concept note which reflects the true nature of a country’s epidemics and an inclusive strategy for combating them.

UNAIDS Guidance for Partnerships with Civil Society, Including People Living with HIV and Key Populations

UNAIDS Guidance for Partnerships with Civil Society, Including People Living with HIV and Key Populations
This document provides guidance on how The Joint United Nations Programme on HIV/AIDS (UNAIDS), its Cosponsors and Secretariat (working at national, regional and global levels) should strengthen and operationalize meaningful and respectful partnership work with civil society. It should enable the UN to deliver the targets and elimination commitments agreed in the 2011 Political Declaration on HIV/AIDS. It assumes that putting partnerships into practice will take place in the context of Getting to Zero (UNAIDS Strategy 2011–2015) and be supported by the Unified Budget, Results and Accountability Framework (UBRAF)—which is, in essence, the UNAIDS work plan to deliver on Getting to Zero—as well as other key UNAIDS programming and budgeting documents.

Getting to Zero: UNAIDS Strategy 2011-2015

Getting to Zero: UNAIDS Strategy 2011-2015
Despite widespread commitment to aid effectiveness principles for HIV, true national ownership and downward accountability are still far from assured. Theinterests of the global South, including those of civil society and people living with and affected by HIV, exercise too little influence in the architecture governing the global AIDS response. The Joint United Nations Programme on HIV/AIDS (UNAIDS) has formed a strategy of transition that aims to see fewer people newly infected than are newly placed on treatment. Doing so will require decisive action guided by a groundbreaking vision: zero new HIV infections, zero discrimination, zero AIDS-related deaths.

 

Media: 

Human Rights for HIV, TB, Malaria and HSS Grants: Information Note

Human Rights for HIV, TB, Malaria and HSS Grants: Information Note
The Global Fund Strategy, Investing for Impact 2012-2016, has five objectives. One of these commits to protecting and promoting human rights by:

Integrating human rights considerations throughout the grant cycle;
Increasing investment in programs that address human rights-related barriers to access; and
Ensuring the Global Fund does not support programs that infringe human rights.

The Global Fund’s mandate focuses on ensuring access to health services and in this way, promoting the right to health. A growing body of evidence demonstrates that the right to health can only be realized if other intersecting human rights are protected, promoted and fulfilled. However, a 2011 UNDP, UNAIDS and Global Fund study found that in settings where key populations are criminalized, Global Fund proposals and grants often did not include human rights programs that benefit the populations who need those services most. In the new funding model, applicants are strongly encouraged to incorporate human rights programming in their concept notes.

Les droits de l’homme dans le cadre des subventions liées au vih, à la tuberculose, au paludisme et au renforcement des systèmes de santé

Les droits de l'homme dans le cadre des subventions liées au vih, à la tuberculose, au paludisme et au renforcement des systèmes de santé
La stratégie 2012-2016 du Fonds mondial de lutte contre le sida, la tuberculose et le paludisme, «Investir pour maximiser l’impact», poursuit cinq objectifs dont celui de protéger et de promouvoir les droits de l’homme : 1. en intégrant la question des droits de l’homme tout au long du cycle de la subvention ; 2. en investissant davantage dans des programmes qui s’attaquent aux obstacles à l’accès liés aux droits de l’homme ; 3. en veillant à ce que le Fonds mondial ne subventionne pas des programmes qui enfreignent les droits de l’homme. Le mandat du Fonds mondial vise à garantir l’accès aux services de santé et, de cette façon, à promouvoir le droit à la santé. Des éléments toujours plus nombreux attestent que le droit à la santé ne peut être réalisé que si d’autres droits de l’homme apparentés sont protégés, promus et respectés. Toutefois, une étude du PNUD, de l’ONUSIDA et du Fonds mondial de 2011 a constaté que, souvent, dans les régions où les populations-clés sont criminalisées, les propositions et les subventions du Fonds mondial n’incluent pas de programmes relatifs aux droits de l’homme dont pourraient bénéficier les populations qui en ont le plus besoin. Dans le cadre du nouveau modèle de financement, les candidats sont vivement encouragés à incorporer à leurs notes conceptuelles une programmation basée sur les droits de l’homme.

Human Rights in the Global Fund New Funding Model

Human Rights in the Global Fund New Funding Model
A summary presentation of the Global Fund’s new funding model for applicants. The core principles for the strategy include:

Invest more strategically
Evolve the funding model
Actively support grant implementation success
Promote and protect human rights

Integrate human rights considerations throughout the grant cycle
Ensure the Global Fund does not support programs that infringe human rights
Increase investment in programs that address human rights barriers to accessing health services

Sustain the gains, mobilize resources